Osteonecrosis of the jaw related to bevacizumab Journal Article

  

Authors:	Estilo, C. L.; Fornier, M.; Farooki, A.; Carlson, D.; Bohle, G. 3rd; Huryn, J. M.
Article Title:	Osteonecrosis of the jaw related to bevacizumab
Keywords:	adult; cancer chemotherapy; human tissue; middle aged; cancer recurrence; case report; angiogenesis inhibitor; bevacizumab; doxorubicin; drug withdrawal; capecitabine; paclitaxel; adjuvant therapy; cancer radiotherapy; radiation dose; temozolomide; multiple cycle treatment; mastectomy; cyclophosphamide; pathology; breast neoplasms; histology; monoclonal antibody; cancer hormone therapy; antibodies, monoclonal; evening dosage; morning dosage; chemically induced disorder; glioblastoma; breast tumor; breast carcinoma; letrozole; chlorhexidine; drug dose increase; angiogenesis inhibitors; bone necrosis; paget nipple disease; jaw disease; jaw diseases; osteonecrosis; carcinoma, ductal, breast; mouthwash; jaw osteonecrosis; gingiva pain
Journal Title:	Journal of Clinical Oncology
Volume:	26
Issue:	24
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2008-08-01
Start Page:	4037
End Page:	4038
Language:	English
DOI:	10.1200/jco.2007.15.5424
PUBMED:	18711196
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-50549088915&partnerID=40&md5=6a61dc9b7fc3c72521bd5c49c924b3c3
Notes:	--- - "Cited By (since 1996): 42" - "Export Date: 17 November 2011" - "CODEN: JCOND" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/14368